SSTR2 positive is significantly lower in poorly differentiated than in well-differentiated neuroendocrine neoplasm, whereas 18F-FDG uptake has been proven to be significantly higher in poorly differentiated than in well-differentiated neuroendocrine neoplasm (16). This evidence concerns the gene SSTR2 and neuroendocrine neoplasm.